Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group)



      While partial nephrectomy (PN) represents the standard surgical management for cT1 renal masses, its role for cT2 tumors is controversial. Robot-assisted PN (RAPN) is being increasingly implemented worldwide.


      To analyze perioperative, functional, and oncological outcomes of RAPN for cT2 tumors.

      Design, setting, and participants

      Retrospective analysis of a large multicenter, multinational dataset of patients with nonmetastatic cT2 masses treated with robotic surgery (ROSULA: RObotic SUrgery for LArge renal mass).


      Robotic-assisted PN.

      Outcome measurements and statistical analysis

      Patients’ demographics, lesion characteristics, perioperative variables, renal functional data, pathology, and oncological data were analyzed. Univariable and multivariable regression analyses assessed the relationships with the risk of intra-/postoperative complications, recurrence, and survival.

      Results and limitations

      A total of 298 patients were analyzed. Median tumor size was 7.6 (7–8.5) cm. Median RENAL score was 9 (8–10). Median ischemia time was 25 (20–32) min. Median estimated blood loss was 150 (100–300) ml. Sixteen patients had intraoperative complications (5.4%), whereas 66 (22%) had postoperative complications (5% were Clavien grade ≥3). Multivariable analysis revealed that a lower RENAL score (odds ratio [OR] 0.46, 95% confidence interval [CI] 0.21–0.65, p = 0.02) and pathological pT2 stage (OR 0.51, 95% CI 0.12–0.86, p = 0.001) were protective against postoperative complications. A total of 243 lesions (82%) were malignant. Twenty patients (8%) had positive surgical margins. Ten deaths and 25 recurrences/metastases occurred at a median follow-up of 12 (5–35) mo. At univariable analysis, higher pT stage was predictive of a likelihood of recurrences/metastases (p = 0.048). While there was a significant deterioration of renal function at discharge, this remained stable over time at 1-yr follow-up. The main limitation of this study is its retrospective design.


      RAPN in the setting of select cT2 renal masses can safely be performed with acceptable outcomes. Further studies are warranted to corroborate our findings and to better define the role of robotic nephron sparing for this challenging indication.

      Patient summary

      This report shows that robotic surgery can be used for safe removal of a large renal tumor in a minimally invasive fashion, maximizing preservation of renal function, and without compromising cancer control.


      To read this article in full you will need to make a payment


      Subscribe to European Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ljungberg B.
        • Bensalah K.
        • Canfield S.
        • et al.
        EAU guidelines on renal cell carcinoma: 2014 update.
        Eur Urol. 2015; 67: 913-924
        • Campbell S.C.
        • Novick A.C.
        • Belldegrun A.
        • et al.
        Guideline for management of the clinical T1 renal mass.
        J Urol. 2009; 182: 1271-1279
        • Van Poppel H.
        • Da Pozzo L.
        • Albrecht W.
        • et al.
        A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
        Eur Urol. 2011; 59: 543-552
        • Mir M.C.
        • Derweesh I.
        • Porpiglia F.
        • Zargar H.
        • Mottrie M.
        • Autorino R.
        Partial nephrectomy versus radical nephrectomy for clinical t1b and t2 renal tumors: a systematic review and meta-analysis of comparative studies.
        Eur Urol. 2017; 71: 606-617
        • Weight C.J.
        • Miller D.C.
        • Campbell S.C.
        • Derweesh I.H.
        • Lane B.R.
        • Messing E.M.
        The management of a clinical T1b renal tumor in the presence of a normal contralateral kidney.
        J Urol. 2013; 189: 1198-1202
        • Porpiglia F.
        • Mari A.
        • Bertolo R.
        • et al.
        Partial nephrectomy in clinical T1b renal tumors: multicenter comparative study of open, laparoscopic and robot-assisted approach (the RECORd project).
        Urology. 2016; 89: 45-51
        • Badalato G.M.
        • Kates M.
        • Wisnivesky J.P.
        • Choudhury A.R.
        • McKiernan J.M.
        Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
        BJU Int. 2012; 109: 1457-1462
        • Kopp R.P.
        • Mehrazin R.
        • Palazzi K.L.
        • et al.
        Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score.
        BJU Int. 2014; 114: 708-718
        • Long C.J.
        • Canter D.J.
        • Kutikov A.
        • et al.
        Partial nephrectomy for renal masses ≥7 cm: technical, oncological and functional outcomes.
        BJU Int. 2012; 109: 1450-1456
        • Becker F.
        • Roos F.C.
        • Janssen M.
        • et al.
        Short-term functional and oncologic outcomes of nephron-sparing surgery for renal tumours ≥7 cm.
        Eur Urol. 2011; 59: 931-937
        • Ficarra V.
        • Bhayani S.
        • Porter J.
        • et al.
        Robot-assisted partial nephrectomy for renal tumors larger than 4 cm: results of a multicenter, international series.
        World J Urol. 2012; 30: 665-670
        • Brandao L.F.
        • Zargar H.
        • Autorino R.
        • et al.
        Robot-assisted partial nephrectomy for ≥7 cm renal masses: a comparative outcome analysis.
        Urology. 2014; 84: 602-608
        • Gupta G.N.
        • Boris R.
        • Chung P.
        • Linehan W.M.
        • Pinto P.A.
        • Bratslavsky G.
        Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up.
        Urol Oncol. 2013; 31: 51-56
        • Serni S.
        • Vittori G.
        • Frizzi J.
        • et al.
        Simple enucleation for the treatment of highly complex renal tumors: perioperative, functional and oncological results.
        Eur J Surg Oncol. 2015; 41: 934-940
        • Malkoc E.
        • Ramirez D.
        • Kara O.
        • et al.
        Robotic and open partial nephrectomy for localized renal tumors larger than 7 cm: a single-center experience.
        World J Urol. 2017; 35: 781-787
        • Masson-Lecomte A.
        • Yates D.R.
        • Bensalah K.
        • et al.
        Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: operative results and preliminary oncologic outcomes from a multicentre French study.
        Eur J Surg Oncol. 2013; 39: 799-803
        • Bertolo R.G.
        • Zargar H.
        • Autorino R.
        • et al.
        Estimated glomerular filtration rate, renal scan and volumetric assessment of the kidney before and after partial nephrectomy: a review of the current literature.
        Minerva Urol Nefrol. 2017; 69: 539-547
        • Novara G.
        • Ficarra V.
        • Antonelli A.
        • et al.
        Corrigendum to “Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?” [Eur Urol 2010;58:588–95].
        Eur Urol. 2011; 59: 182
        • Kutikov A.
        • Smaldone M.C.
        • Egleston B.L.
        • et al.
        Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL nephrometry score.
        Eur Urol. 2011; 60: 241-248
        • Dindo D.
        • Demartines N.
        • Clavien P.A.
        Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
        Surgery. 2004; 240: 205-213
        • Paner G.P.
        • Stadler W.M.
        • Hansel D.E.
        • Montironi R.
        • Lin D.W.
        • Amin M.B.
        Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers.
        Eur Urol. 2018; 73: 560-569
        • Fuhrman S.A.
        • Lasky L.C.
        • Limas C.
        Prognostic significance of morphologic parameters in renal cell carcinoma.
        Am J Surg Pathol. 1982; 6: 655-663
        • Bellomo R.
        • Ronco C.
        • Kellum J.A.
        • Mehta R.L.
        • Palevsky P.
        • the A.D.Q.I.
        • Workgroup
        Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.
        Crit Care. 2004; 8: R204-R212
        • Zargar H.
        • Porpiglia F.
        • Porter J.
        • et al.
        Achievement of trifecta in minimally invasive partial nephrectomy correlates with functional preservation of operated kidney: a multi-institutional assessment using MAG3 renal scan.
        World J Urol. 2016; 34: 925-931
      1. Porpiglia F, Fiori C, Checcucci E, Amparore D, Bertolo R. Hyperaccuracy three-dimensional reconstruction is able to maximize the efficacy of selective clamping during robot-assisted partial nephrectomy for complex renal masses. Eur Urol. In press.

        • Volpe A.
        • Blute M.L.
        • Ficarra V.
        • et al.
        Renal ischemia and function after partial nephrectomy: a collaborative review of the literature.
        Eur Urol. 2015; 68: 61-74
        • Winoker J.S.
        • Paulucci D.J.
        • Anastos H.
        • et al.
        Predicting complications following robot-assisted partial nephrectomy with the ACS NSQIP(®) universal surgical risk calculator.
        J Urol. 2017; 198: 803-809
        • Zaid H.B.
        • Parker W.P.
        • Lohse C.M.
        • et al.
        Patient factors associated with 30-day complications after partial nephrectomy: a contemporary update.
        Urol Oncol. 2017; 35: 153
        • Abdel Raheem A.
        • Alatawi A.
        • Kim D.K.
        • et al.
        Outcomes of high-complexity renal tumours with a Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) score of ≥10 after robot-assisted partial nephrectomy with a median 46.5-month follow-up: a tertiary centre experience.
        BJU Int. 2016; 118: 770-778
        • Rajan S.
        • Babazade R.
        • Govindarajan S.R.
        • et al.
        Perioperative factors associated with acute kidney injury after partial nephrectomy.
        Br J Anaesth. 2016; 116: 70-76
        • Mamut A.E.
        • Violette P.D.
        • Rowe N.E.
        • Cui F.
        • Luke P.P.
        Measuring the impact of medical chronic kidney disease and diabetes mellitus on renal functional decline following surgical management of renal masses.
        Urology. 2016; 91: 124-127
        • Zhang Z.
        • Zhao J.
        • Dong W.
        • et al.
        Acute kidney injury after partial nephrectomy: role of parenchymal mass reduction and ischemia and impact on subsequent functional recovery.
        Eur Urol. 2016; 69: 745-752
        • Porpiglia F.
        • Fiori C.
        • Bertolo R.
        • et al.
        Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors.
        Eur Urol. 2012; 62: 130-135
        • Mouracade P.
        • Kara O.
        • Dagenais J.
        • et al.
        Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
        World J Urol. 2017; 35: 1425-1433
        • Hansen J.
        • Sun M.
        • Bianchi M.
        • et al.
        Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.
        Urology. 2012; 80: 347-353
        • Alanee S.
        • Herberts M.
        • Holland B.
        • Dynda D.
        Contemporary experience with partial nephrectomy for stage T2 or greater renal tumors.
        Curr Urol Rep. 2016; 17: 5
        • Fero K.
        • Hamilton Z.A.
        • Bindayi A.
        • Murphy J.D.
        • Derweesh I.H.
        Utilization and quality outcomes of cT1a, cT1b and cT2a partial nephrectomy: analysis of the national cancer database.
        BJU Int. 2018; 121: 565-574
        • Bensalah K.
        • Pantuck A.J.
        • Rioux-Leclercq N.
        • et al.
        Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
        Eur Urol. 2010; 57: 466-471
        • Khalifeh A.
        • Kaouk J.H.
        • Bhayani S.
        • et al.
        Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind).
        J Urol. 2013; 190: 1674-1679

      Linked Article